NEW YORK (GenomeWeb) — OpGen reported after the close of the market Tuesday a 26 percent drop in its third quarter revenues, citing lower sales of its legacy QuickFISH rapid pathogen diagnostic products.
For the three months ended Sept. 30, OpGen's revenues fell to $552,221 from $745,114 in the same period the year before, pulled down by the decline in QuickFISH revenues, and in line with previously disclosed estimates.